The genetic defect associated with decreased response to interferon therapy to Hepatitis C is:
Some patients with hepatitis C may not respond well to treatment with interferon as expected. They are harboring genetic variation in IL28B usually. Ref: Harrison, Edition-18, Page-42
IL28B
IL15
c-KIT
NAT2